Plain-English translation of NCT07854600 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called combined with a chemotherapy regimen (GEMOX) to treat biliary tract cancer — a cancer affecting the bile ducts or gallbladder. The study will enroll 87 patients with advanced disease to see if this combination treatment can shrink tumors enough to allow surgery or improve survival and safety outcomes.
Bile duct cancer is often diagnosed at an advanced stage when surgery alone may not be possible or when the risk of cancer returning is very high. This trial is exploring whether adding this new immunotherapy medication to standard chemotherapy before surgery can help more patients achieve successful treatment and reduce the chance of recurrence.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive 3 to 6 cycles of the medication combined with chemotherapy, given over several months, before undergoing surgical evaluation to remove your tumor. You will need to attend regular clinic visits for treatment infusions, blood tests, and imaging scans to monitor how the treatment is working. After completing this treatment phase, your doctors will reassess whether surgery is possible and proceed accordingly.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
China